TEVA 5526 Pill - blue capsule/oblong, 19mm
Pill with imprint TEVA 5526 is Blue, Capsule/Oblong and has been identified as Atazanavir Sulfate 150 mg. It is supplied by Teva Pharmaceuticals USA, Inc.
Atazanavir is used in the treatment of Nonoccupational Exposure; HIV Infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Atazanavir 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 5526
Atazanavir Sulfate
- Imprint
- TEVA 5526
- Strength
- 150 mg
- Color
- Blue
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- Manufacturer
- Pliva Hrvatska d.o.o.
- National Drug Code (NDC)
- 00093-5526
- Inactive Ingredients
-
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
ferrosoferric oxide,
lactose monohydrate,
magnesium stearate,
propylene glycol,
shellac,
sodium lauryl sulfate,
sorbitan monolaurate,
titanium dioxide
Note: Inactive ingredients may vary.
More about atazanavir
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: protease inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
